Acurx Pharmaceuticals Stock Forecast

ACXP's stock price has decreased by -79.13% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Acurx Pharmaceuticals stock have an average target of 143.67, with a low estimate of 31 and a high estimate of 240. The average target predicts an increase of 4,375.70% from the current stock price of 3.21.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$31	$143.67	$160	$240
Change	+865.73%	+4375.7%	+4884.4%	+7376.6%

* Price targets were last updated on Sep 30, 2025.

Analyst Ratings

The average analyst rating for Acurx Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	2	2	3	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Keller HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $31	Strong Buy	Reiterates	$31	+865.73%	Sep 30, 2025
Matthew Keller HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $8 → $31	Strong Buy	Maintains	$8 → $31	+865.73%	Aug 12, 2025
Matthew Kelsey HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $160	Strong Buy	Initiates	$160	+4,884.42%	May 15, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $240	Strong Buy	Reiterates	$240	+7,376.64%	Mar 19, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $240	Strong Buy	Reiterates	$240	+7,376.64%	Jan 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-5.81

from -17.45

EPS Next Year

-3.88

from -5.81

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-14.86	-29.87	-22.36	-23.01	-17.45	-5.81	-3.88
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-5.96	-2.89
Avg	-5.81	-3.88
Low	-5.61	-4.57

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.